AML leverages cell-based assays and biomarker analysis in preclinical and translational MOA studies.

  • Bank of over 100 human tumor cell lines
  • Cell Proliferation
  • Cell Cycle Analysis
  • Apoptosis/Senescence Assays
  • Migration/Invasion Assays
  • Combination Drug Studies
  • Over-expression and knock-down studies